Unapproved and Misleaded Compounded GLP-1s
Dr. Marty Makary Commissioner U.S. Food and Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20993 Re: Support for FDA Action to Address Unapproved and Misleading Compounded GLP-1 Drugs Dear Commissioner Makary: We write to applaud the FDA’s February 6, 2026 announcement to take decisive action against mass-marketed, non-FDA-approved GLP-1 drugs that put [...]